Corrigendum to "Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial" [Neurotherapeutics 21 (3) (2024) e00331]

Affiliations

• ¹ Biomedical Engineering, University of Manitoba, Winnipeg, MB Canada; Riverview Health Center, Winnipeg, MB Canada. Electronic address: Zahra.Moussavi@umanitoba.ca.
• ² Biomedical Engineering, University of Manitoba, Winnipeg, MB Canada.
• ³ Biomedical Engineering, University of Manitoba, Winnipeg, MB Canada; Riverview Health Center, Winnipeg, MB Canada; Monash Alfred Psychiatry Research Center, Prahran, Victoria, Australia.
• ⁴ Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB Canada.
• ⁵ Warren Centre for Actuarial Studies and Research, University of Manitoba, Winnipeg, MB Canada.
• ⁶ Brain Vision and Concussion Clinic, Winnipeg, MB Canada.
• ⁷ Psychiatry, University of Manitoba, Winnipeg, MB Canada.
• ⁸ Neurology & Neurosurgery, McGill University, Montreal, QC Canada.
• ⁹ School of Medicine and Psychology, ANU College of Health and Medicine, Canberra, NSW Australia.
• ¹⁰ Clinical Psychology, McGill University, Montreal, QC Canada.